EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Echocardiographic Phenotype of Cardiac Wasting in Patients with Advanced Cancer

Markus S Anker iD, Muhammad Shahzeb Khan, Anja Nikolski, Jan Porthun, Muhammad Sameer Arshad, Sara Hadzibegovic, Alessia Lena, Lucie Kretzler, Jonathan L Hella, Marco Witkowski, Kathrin Rieger, Johann Ahn und 16 weitere

European Journal of Heart Failure · 01.11.2025 · 27 (11) · 2130-2140

DOI: 10.1002/ejhf.3744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 06.08.2025. Verfasst von Markus S Anker und 27 weiteren Autor:innen. Beteiligte Einrichtung: Charité - University Medicine Berlin corporate member of Free University Berlin and Humboldt-University Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Neoplasms, Cardiomyopathies, Heart Ventricles, Ventricular Function, Left. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Centre for Cardiovascular Research, Deutsches Zentrum für Herz-Kreislaufforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiac wasting-associated cardiomyopathy in patients with advanced cancer is characterized by loss of left ventricular (LV) mass and independently associated with poor prognosis. Better understanding of this very prevalent cardiomyopathy is urgently needed. Methods and results Overall, 398 patients with active, mostly advanced cancer without significant cardiovascular disease (mean LV ejection fraction [LVEF] 64.3 ± 0.2%) or active infection were prospectively examined (mean age 60 ± 1 years, 50% women, body mass index 25.0 ± 0.2 kg/m2, 26% cachectic). Patients were categorized and compared by quartiles of LV mass/height2. LVEF, global longitudinal strain (GLS), and anticancer therapy naive status were similar across quartiles. Patients in Q1 (lowest LV mass quartile) were younger, more likely cachectic, had lower: BMI, 10-step stair-climbing power, tricuspid annular plane systolic excursion (TAPSE), stroke volume, cardiac output, and higher heart rate. In repeat follow-up assessments after 140 ± 8 days (n = 143), LVEF, TAPSE, LV mass, left atrial volume, and GLS were found reduced (all p ≤ 0.002). Only in those with above-median LV mass at baseline, cardiac output and heart rate increased during follow-up – in those with below-median LV mass, mitral E/A decreased.

Conclusions

Patients with advanced cancer with low LV mass have a distinct phenotype characterized by lower cardiac chamber volumes, stroke volume, and cardiac output, but normal LVEF and GLS that may be the distinct feature of cardiac wasting-associated cardiomyopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCardiomyopathiesHeart VentriclesVentricular Function, LeftCachexiaHumansFemaleMaleMiddle AgedStroke VolumeEchocardiographyProspective StudiesPhenotypeAgedPrognosis

Stichwörter der Autor:innen

CancerCardiac wasting cardiomyopathyEchocardiographyLeft ventricular massPathophysiology

Autor:innen und Institutionen

  • Charité - University Medicine Berlin corporate member of Free University Berlin and Humboldt-University Berlin, Berlin, Germany.
  • German Centre for Cardiovascular Research partner site Berlin, and Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany.
  • Department of Cardiology, Angiology and Intensive Care Medicine CBF, German Heart Center Charité, Berlin, Germany.
  • School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Baylor Scott and White Heart Hospital, Plano, Texas, USA.
  • Baylor College of Medicine, Temple, Texas, USA.

ORCID-Profile: Markus S Anker

Förderung

  • German Centre for Cardiovascular Research
  • Deutsches Zentrum für Herz-Kreislaufforschung

Zitieren

APA

Anker, M. S., Khan, M. S., Nikolski, A., Porthun, J., Arshad, M. S., Hadzibegovic, S., Lena, A., Kretzler, L., Hella, J. L., Witkowski, M., Rieger, K., Ahn, J., Modest, D. P., Keller, U., Bullinger, L., Totzeck, M., Mahabadi, A. A., Rassaf, T., Buchmann, N., …, & Landmesser, U. (2025). Clinical and Echocardiographic Phenotype of Cardiac Wasting in Patients with Advanced Cancer. European Journal of Heart Failure, 27(11), 2130-2140. https://doi.org/10.1002/ejhf.3744

Vancouver

Anker MS, Khan MS, Nikolski A, Porthun J, Arshad MS, Hadzibegovic S, et al. Clinical and Echocardiographic Phenotype of Cardiac Wasting in Patients with Advanced Cancer. European Journal of Heart Failure. 2025;27(11):2130-2140. doi:10.1002/ejhf.3744

BibTeX
@article{Anker2025,
  author = {Anker, Markus S and Khan, Muhammad Shahzeb and Nikolski, Anja and Porthun, Jan and Arshad, Muhammad Sameer and Hadzibegovic, Sara and Lena, Alessia and Kretzler, Lucie and Hella, Jonathan L and Witkowski, Marco and Rieger, Kathrin and Ahn, Johann and Modest, Dominik P and Keller, Ulrich and Bullinger, Lars and Totzeck, Matthias and Mahabadi, Amir A and Rassaf, Tienush and Buchmann, Nikolaus and Attanasio, Philipp and Zeller, Tanja and Karakas, Mahir and Tocchetti, Carlo G and Wilkenshoff, Ursula and Cleland, John G F and von Haehling, Stephan and Butler, Javed and Landmesser, Ulf},
  title = {Clinical and Echocardiographic Phenotype of Cardiac Wasting in Patients with Advanced Cancer},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {11},
  pages = {2130--2140},
  doi = {10.1002/ejhf.3744}
}
Kostenlos starten →